ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.89
0.70%
US Tech 100
18,062.00
-0.10%
S&P 500
5,303.27
0.12%
US Dollar vs CAD
1.36165
-0.01%
Bitcoin
66,915.13
-0.25%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Evoke Pharma Inc (EVOK)

  7. Evoke Pharma Inc (EVOK) News

EVOK

Evoke Pharma (EVOK)

Evoke Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EVOK
DateTimeSourceHeadlineSymbolCompany
05/16/20243:02PMGlobeNewswire Inc.Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) ConferenceNASDAQ:EVOKEvoke Pharma Inc
05/14/20243:58PMEdgar (US Regulatory)Form ARS/A - Annual Report to Security Holders: [Amend]NASDAQ:EVOKEvoke Pharma Inc
05/14/20243:20PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EVOKEvoke Pharma Inc
05/14/20243:15PMGlobeNewswire Inc.Evoke Pharma Reports First Quarter 2024 Financial ResultsNASDAQ:EVOKEvoke Pharma Inc
05/14/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EVOKEvoke Pharma Inc
05/14/20243:05PMEdgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:EVOKEvoke Pharma Inc
05/14/20243:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EVOKEvoke Pharma Inc
04/17/20247:30AMGlobeNewswire Inc.Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 MedicationsNASDAQ:EVOKEvoke Pharma Inc
03/21/20243:15PMGlobeNewswire Inc.Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D’Onofrio to Chief Executive OfficerNASDAQ:EVOKEvoke Pharma Inc
03/14/20243:05PMGlobeNewswire Inc.Evoke Pharma Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:EVOKEvoke Pharma Inc
03/07/20243:10PMGlobeNewswire Inc.Evoke Pharma to Report Fourth Quarter and Full Year 2023 Results on March 14, 2024NASDAQ:EVOKEvoke Pharma Inc
02/23/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EVOKEvoke Pharma Inc
02/20/20243:38PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:EVOKEvoke Pharma Inc
02/14/20248:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EVOKEvoke Pharma Inc
02/14/20246:30AMGlobeNewswire Inc.Evoke Pharma Announces Closing of $7.5 Million Public OfferingNASDAQ:EVOKEvoke Pharma Inc
02/09/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EVOKEvoke Pharma Inc
02/09/20244:14PMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:EVOKEvoke Pharma Inc
02/09/20246:30AMGlobeNewswire Inc.Evoke Pharma Announces Pricing of Underwritten Public Offering of up to $30 MillionNASDAQ:EVOKEvoke Pharma Inc
02/08/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:EVOKEvoke Pharma Inc
02/08/20245:50AMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:EVOKEvoke Pharma Inc
01/10/20248:38PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:EVOKEvoke Pharma Inc
01/04/20243:30PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:EVOKEvoke Pharma Inc
12/19/20237:30AMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:EVOKEvoke Pharma Inc
12/15/20233:30PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:EVOKEvoke Pharma Inc
11/29/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EVOKEvoke Pharma Inc
11/27/20233:30PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EVOKEvoke Pharma Inc
11/27/20237:30AMGlobeNewswire Inc.Evoke Pharma Announces FDA Orange Book Listing of New GIMOTI PatentNASDAQ:EVOKEvoke Pharma Inc
11/22/20233:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:EVOKEvoke Pharma Inc
11/14/20237:30AMGlobeNewswire Inc.United States Patent and Trademark Office (USPTO) Grants Another Formulation Patent Covering GIMOTINASDAQ:EVOKEvoke Pharma Inc
11/09/20233:30PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:EVOKEvoke Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:EVOK

Your Recent History

NASDAQ
BTMD
Biote
TSX
BGC
Bristol Gate Concentrate...
NYSE
CNA
CNA Financial
BIT
UC5LUV
Unicredit Bank
LSE
76TX
Agric Dev Bk 24
USOTC
UMAX
Umax (PK)
GATE
OPULUSDT
OpulousToken
NYSE
BNRE
Brookfield Reinsurance
ASX
WBCHBN
Westpac Banking
KUCN
PLAYETH
HEROcoin
KOSPI
004800
Hyosung
GATE
ASSUSDT
Australian Shepherd Token
LBNK
DLXUSDT
DAppLinks
TSXV
ORN
USOTC
MFDB
Mutual Federal Bancorp (PK)
BIT
F17560
Vontobel Financial Produ...
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved